Skip Navigation

Elacestrant Monotherapy for the Treatment of Postmenopausal Women with ER+/HER2- Advanced Breast Cancer Following Cdk4/6 Inhibitor Therapy: A Phase III Randomized, Open-Label, Multicenter Trial EMERALD

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03778931

Study #:
STUDY00143504

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03778931

View Complete Trial Details & Eligibility at ClinicalTrials.gov